| Risk | Moderately High |
|---|---|
| Min SIP Amount | Not Supported |
| Expense Ratio | 1.38% |
| NAV | ₹7.54 (26 Oct 2020) |
|---|---|
| Fund Started | 05 Mar 2018 |
| Fund Size | ₹138 Cr |
| Name | Sector | Instrument | % Assets |
|---|---|---|---|
| Navin Fluorine International Ltd. | Chemicals | Equity | 5.5% |
| Thyrocare Technologies Ltd. | Healthcare | Equity | 3.8% |
| Grindwell Norton Ltd. | Metals | Equity | 3.4% |
| Timken India Ltd. | Engineering | Equity | 3.1% |
| JK Cement Ltd | Construction | Equity | 3.0% |
| Rossari Biotech Ltd. | Chemicals | Equity | 2.6% |
| Johnson Controls - Hitachi Air Conditioning India Ltd. | Cons Durable | Equity | 2.4% |
| Orient Electric Ltd. | Engineering | Equity | 2.3% |
| Heidelberg Cement India Ltd. | Construction | Equity | 2.2% |
| India Cements Ltd. | Construction | Equity | 2.0% |
Sundaram Emerging Small Cap Series 1 Regular Growth is a Equity Mutual Fund Scheme launched by Sundaram Mutual Fund. This scheme was made available to investors on 05 Mar 2018. S Krishnakumar, Dwijendra Srivastava is the Current Fund Manager of Sundaram Emerging Small Cap Series 1 Regular Growth fund.The fund currently has an Asset Under Management(AUM) of ₹138 Cr and the Latest NAV as of 26 Oct 2020 is ₹7.54.
The Sundaram Emerging Small Cap Series 1 Regular Growth is rated Moderately High risk.
The scheme seeks capital appreciation by investing predominantly in equity/equity-related instruments of companies that can be termed as Small Caps.